Similar articles

• Comparative effects of prazosin and phenoxybenzamine on arterial blood pressure, heart rate, and plasma catecholamines in essential hypertension.

  Mulvihill-Wilson J, Graham RM, Pettinger W, Muckleroy C, Anderson S, Gaffney FA, Blomqvist CG. Mulvihill-Wilson J, et al. J Cardiovasc Pharmacol. 1979 Nov-Dec;1(6 Suppl):S1-7. J Cardiovasc Pharmacol. 1979. PMID: 94635 No abstract available.
• Hemodynamic and neuroendocrine responses to acute and chronic alpha-adrenergic blockade with prazosin and phenoxybenzamine.

  Mulvihill-Wilson J, Gaffney FA, Pettinger WA, Blomqvist CG, Anderson S, Graham RM. Mulvihill-Wilson J, et al. Circulation. 1983 Feb;67(2):383-93. doi: 10.1161/01.cir.67.2.383. Circulation. 1983. PMID: 6129077 Clinical Trial.
• Alpha-adrenergic blocking activity of prazosin. Effect on catecholamine levels and catecholamine synthetic enzymes.

  Atkins FL, Nicolosi GL. Atkins FL, et al. Biochem Pharmacol. 1979 Apr 1;28(7):1233-7. doi: 10.1016/0006-2952(79)90335-6. Biochem Pharmacol. 1979. PMID: 36093 No abstract available.
• Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.

  Stanaszek WF, Kellerman D, Brogden RN, Romankiewicz JA. Stanaszek WF, et al. Drugs. 1983 Apr;25(4):339-84. doi: 10.2165/00003495-198325040-00002. Drugs. 1983. PMID: 6303744 Review.
• Alpha-adrenergic blockade in the treatment of essential hypertension.

  De Leeuw PW, Birkenhäger WH. De Leeuw PW, et al. Neth J Med. 1983;26(9):274-82. Neth J Med. 1983. PMID: 6140644 Review. No abstract available.